Probenecid 500 mg

DRUG2 trials

Sponsors

Washington State University, TrippBio, Inc.

Conditions

Endogenous BiomarkersInteractionRelative Bioavailability

Early Phase 1

Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters

CompletedNCT05365451

Washington State UniversityEndogenous Biomarkers, Interaction

Start: 2022-04-11End: 2023-07-22Updated: 2025-08-08

Phase 1

A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml)

CompletedNCT06025344

TrippBio, Inc.Relative Bioavailability

Start: 2024-09-01End: 2024-10-15Updated: 2024-11-21